Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis
Tate Johnson, Harlan Sayles, Joshua F. Baker, Michael George, Punyasha Roul, Cheng Zheng, Brian C. Sauer, Katherine P. Liao, Daniel R. Anderson, Ted R. Mikuls, Bryant R. England
Topics & Concepts
MedicineRheumatoid arthritisInternal medicineMethotrexateConfoundingCoronary artery diseaseDiseaseProspective cohort studyCohort studyHazard ratioStroke (engine)Confidence intervalEngineeringMechanical engineeringRheumatoid Arthritis Research and TherapiesGout, Hyperuricemia, Uric AcidInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis